Published on
July 21, 2026
- 13:00 GMT
i-Lumen Scientific Announces 1st U.S. Patient Randomized in i-SIGHT2 Pivotal Study for Intermediate to Advanced Dry AMD
Milestone initiates U.S. pivotal clinical trial of the i-Lumen AMD System for patients with intermediate to advanced dry age-related macular degeneration BLOOMINGTON, MN, UNITED STATES, July 21, 2026 /EINPresswire.com/ -- i-Lumen Scientific, Inc., a …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Technology
...
